Covid-19. April 23

Green passport. Covid-19. EC photo

Sodra has joined the government’s initiative to promote vaccination among the elderly. The Sodra Information Centre is calling over 112,000 people from all over Lithuania who have not been vaccinated so far and invites them to the procedure.

“Dear seniors, if you have not yet been vaccinated against COVID-19, we invite you for a free vaccine. This is the only scientifically proven way to protect yourself against this dangerous virus and an opportunity to return to normal life. If you have not yet received an invitation to the procedure, please contact your municipality. For more information, visit www.koronastop.lt. Let’s be healthy – for ourselves and for those we love,” this is the message that pensioners who received a call from Sodra hear.

“Today, it is especially important that we are united in the fight against the pandemic. Let us encourage the elderly to take the opportunity to get vaccinated. It is important to help them understand that all vaccines used in Lithuania are safe and can protect us. The common goal of each of us today is to achieve the greatest possible resilience and restore people to normal lives,” says Monika Navickienė, Minister of Social Security and Labour.

On Friday, Prime Minister Ingrida Šimonytė visited vaccination centres in Trakai, Elektrėnai and Kaišiadorys. After the visit to Trakai, the prime minister admitted that the inhabitants of some regions expect that they will be vaccinated with the Russian Sputnik V vaccine, but I. Šimonytė firmly denied that it would not be used in Lithuania.

“I spoke to the head of the health clinic, who clearly stated that some of the residents are waiting for Sputnik. “These people are not anti-vaccers – that is, they can be persuaded to vaccinate, but Lithuania neither intends to buy nor does it intend to order Sputnik-V and will rely on the vaccines that we have purchased under joint EU procurement,” I. Šimonytė told reporters after visiting Trakai.

After the company Johnson & Johnson informed that it proposes to start the distribution and vaccination of its vaccine against COVID-19, 4,800 vaccines, which are already in Lithuania, will be handed over to vaccination centres on Wednesday.

The Johnson & Johnson vaccine is a single-dose vaccine.

Seniors, patients with chronic diseases treated in hospitals will be offered these vaccines, as well as people going to work in Lithuanian diplomatic and consular institutions abroad.

The first shipment of Johnson & Johnson vaccines arrived in Lithuania on April 13, but the manufacturer asked for the vaccine to be suspended pending investigation of rare side effects in the United States. The European Medicines Agency (EMA) said on Tuesday that the unusual blood clots should be described as a “very rare” side effect of the Johnson & Johnson vaccine against the coronavirus but stressed that the benefits of the vaccines still outweigh the risks.

Johnson & Johnson was supposed to be innovative – build immunity quickly and be effective even after one dose.

Minister of Economy and Innovation Aušrinė Armonaitė announced on Tuesday that programmers are already working on creating the so-called Electronic Passport of Opportunities.

The Opportunities Passport is to be an electronic document that would allow people who are vaccinated, recovered or who have performed a coronavirus test to participate in mass events, concerts, visit sports clubs, bars, clubs or restaurants.

In an interview with journalists, the minister said she hopes that the initiative will start in a few weeks. It is true that the government has not yet adopted the final shape of the Passport, but the minister assured that it was a matter of days.

“The plan doesn’t change, the programmers are working. As I mentioned last week, the work will be finished in two to three weeks. There will be three elements: vaccine, disease and tests,” said A. Armonaitė on Tuesday.

She also noted that a negative test result would allow access to the passport for 48 hours.

You may like

Be the first to comment

Leave a Reply

Your email address will not be published.


*